Increased DNA Methyltransferase 1 (DNMT1) Protein Expression in Precancerous Conditions and Ductal Carcinomas of the Pancreas

Overview

Journal Cancer Sci

Specialty Oncology

Date 2005 Aug 2

PMID 16053511

Citations 57

Authors

Dun-Fa Peng

Yae Kanai

Morio Sawada

Saori Ushijima

Nobuyoshi Hiraoka

Tomoo Kosuge

Setsuo Hirohashi

Affiliations

Soon will be listed here.

Abstract

Aberrant DNA methylation has been shown to play an important role during multistage carcinogenesis in various human organs. The aim of the present study was to evaluate the significance of DNA methyltransferase 1 (DNMT1) protein expression during pancreatic carcinogenesis. Immunohistochemical analysis of DNMT1 in 48 peripheral pancreatic duct epithelia showing no remarkable histological findings without an inflammatory background (DE), 54 peripheral pancreatic duct epithelia with an inflammatory background (DEI), 188 pancreatic intraepithelial neoplasias (PanIN), and 220 areas of invasive ductal carcinoma from surgical specimens resected from 100 patients, was carried out. The average incidence of DNMT1 immunoreactivity increased progressively from DE to DEI (P = 0.003), from DE and DEI to PanIN (P < 0.0001), among PanIN with different grades of dysplasia (from PanIN I to PanIN II, P = 0.0012), from PanIN to invasive ductal carcinomas (P < 0.0001) and among invasive ductal carcinomas with different grades of histological differentiation (from well or moderately to poorly differentiated adenocarcinomas, P < 0.0001). High-level DNMT1 protein expression in invasive ductal carcinomas was correlated significantly with an advanced t category (P = 0.0224) and an advanced stage (P = 0.0294). Moreover, patients with invasive ductal carcinomas showing high-level DNMT1 protein expression had a poorer outcome (P = 0.0469). These data suggest that increased DNMT1 protein expression participates in multistage pancreatic carcinogenesis from the precancerous stage to malignant progression of ductal carcinomas and may be a biological predictor of poor prognosis.

Citing Articles

Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma.

Oyon D, Lopez-Pascual A, Castello-Uribe B, Uriarte I, Orsi G, Llorente S J Exp Clin Cancer Res. 2025; 44(1):13.

PMID: 39810240 PMC: 11734372. DOI: 10.1186/s13046-024-03268-5.

Molecular pathological approach to cancer epigenomics and its clinical application.

Kanai Y Pathol Int. 2024; 74(4):167-186.

PMID: 38482965 PMC: 11551818. DOI: 10.1111/pin.13418.

Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes.

Liu Y, Liu N, Zhou X, Zhao L, Wei W, Hu J Front Endocrinol (Lausanne). 2023; 14:1245629.

PMID: 37876534 PMC: 10591078. DOI: 10.3389/fendo.2023.1245629.

A Porcine DNMT1 Variant: Molecular Cloning and Generation of Specific Polyclonal Antibody.

Zhu L, Wang J, Zhang Y, Xiang X, Liu K, Wei J Genes (Basel). 2023; 14(7).

PMID: 37510229 PMC: 10379332. DOI: 10.3390/genes14071324.

An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.

Sahafnejad Z, Ramazi S, Allahverdi A Genes (Basel). 2023; 14(4).

PMID: 37107631 PMC: 10137918. DOI: 10.3390/genes14040873.

References

Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M . Cancer statistics, 2003. CA Cancer J Clin. 2003; 53(1):5-26. DOI: 10.3322/canjclin.53.1.5. View

Hruban R, Adsay N, Albores-Saavedra J, Compton C, Garrett E, Goodman S . Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001; 25(5):579-86. DOI: 10.1097/00000478-200105000-00003. View

Toyota M, Ahuja N, Herman J, Baylin S, Issa J . CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999; 96(15):8681-6. PMC: 17576. DOI: 10.1073/pnas.96.15.8681. View

Luttges J, Schlehe B, Menke M, Vogel I, Henne-Bruns D, Kloppel G . The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer. 1999; 85(8):1703-10. View

Matsuno S, Egawa S, Fukuyama S, Motoi F, Sunamura M, Isaji S . Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas. 2004; 28(3):219-30. DOI: 10.1097/00006676-200404000-00002. View

Kanai Y, Ushijima S, Kondo Y, Nakanishi Y, Hirohashi S . DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int J Cancer. 2001; 91(2):205-12. DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1040>3.0.co;2-2. View

Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S . Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology. 2001; 33(3):561-8. DOI: 10.1053/jhep.2001.22507. View

Chuang L, Ian H, Koh T, Ng H, Xu G, Li B . Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science. 1997; 277(5334):1996-2000. DOI: 10.1126/science.277.5334.1996. View

Sato N, Maitra A, Fukushima N, Van Heek N, Matsubayashi H, Iacobuzio-Donahue C . Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res. 2003; 63(14):4158-66. View

10.

Jones P, Baylin S . The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002; 3(6):415-28. DOI: 10.1038/nrg816. View

11.

Howes N, Neoptolemos J . Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Gut. 2002; 51(6):765-6. PMC: 1773485. DOI: 10.1136/gut.51.6.765. View

12.

Bestor T . Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. EMBO J. 1992; 11(7):2611-7. PMC: 556736. DOI: 10.1002/j.1460-2075.1992.tb05326.x. View

13.

Kanai Y, Ushijima S, Ochiai A, Eguchi K, Hui A, Hirohashi S . DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis. Cancer Lett. 1998; 122(1-2):135-41. DOI: 10.1016/s0304-3835(97)00380-7. View

14.

Kanai Y, Ushijima S, Tsuda H, Sakamoto M, Hirohashi S . Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett. 2000; 148(1):73-80. DOI: 10.1016/s0304-3835(99)00316-x. View

15.

Rhee I, Bachman K, Park B, Jair K, Yen R, Schuebel K . DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002; 416(6880):552-6. DOI: 10.1038/416552a. View

16.

Yamano M, Fujii H, Takagaki T, Kadowaki N, Watanabe H, Shirai T . Genetic progression and divergence in pancreatic carcinoma. Am J Pathol. 2000; 156(6):2123-33. PMC: 1850062. DOI: 10.1016/S0002-9440(10)65083-3. View

17.

Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H . Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer. 2003; 105(4):527-32. DOI: 10.1002/ijc.11127. View

18.

Kanai Y, Hui A, Sun L, Ushijima S, Sakamoto M, Tsuda H . DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Hepatology. 1999; 29(3):703-9. DOI: 10.1002/hep.510290338. View

19.

Kanai Y, Ushijima S, Hui A, Ochiai A, Tsuda H, Sakamoto M . The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer. 1997; 71(3):355-9. DOI: 10.1002/(sici)1097-0215(19970502)71:3<355::aid-ijc8>3.0.co;2-x. View

20.

Eguchi K, Kanai Y, Kobayashi K, Hirohashi S . DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res. 1997; 57(21):4913-5. View